Cangrelor

🧮 Dose calculator

Acute coronary syndrome / post-MI · Regimen source: FDA Kengreal · 2.1

Enter age and weight.

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Kengreal · 8.1

  “Risk Summary There are no available data on cangrelor use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Kengreal · 8.2

  “Risk Summary There are no data on the presence of cangrelor in human milk or animal milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Kengreal · 8.4

  “Safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Kengreal · 8.5

  “No overall differences in safety or effectiveness were observed between these patients and those patients <75 years [see Clinical Studies ( 14.1 )] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.